natgillin/translations-raw huggingface dataset:
If needed, an F-test or likelihood ratio test can be used to assist in the choice of the appropriate growth model (OECD monograph 54, (32).
Prema potrebi, moguće je upotrijebiti F-test ili test omjera vjerojatnosti radi lakšeg odabiranja odgovarajućeg modela rasta (Monografija OECD-a br. 54, literatura (32.)).
These percentages assume that the analytical methods are reliable and the half life is < 14 days.
U tim se postotcima podrazumijeva da su analitičke metode pouzdane i da trajanje poluvijeka iznosi < 14 dana.
If the analytical methods are less reliable or the half life is (greatly) increased these numbers will become larger.
Ako su analitičke metode manje pouzdane ili je poluvijek (znatno) produžen, ti će brojevi porasti.
CI confidence interval (where possible to estimate)
CI interval pouzdanosti (ako ga je moguće procijeniti)
SD Standard deviation (where possible to estimate)
SD standardna devijacija (ako ju je moguće procijeniti)
The minimised test may in fact be used to demonstrate rapid metabolism when it is known that rapid metabolism is likely.
Skraćeno bi se ispitivanje zapravo moglo upotrijebiti za dokazivanje brzog metaboliziranja kad je poznato da bi do njega moglo doći.
When only two data points are measured, estimates of the confidence limits for BCFKm can be made using bootstrap methods.
Ako se mjere samo dvije podatkovne točke, moguće je procijeniti granice pouzdanosti za vrijednost BCFKm upotrebom metode samodopunjavanja (‚bootstrap’).
When intermediate data points are also available confidence limits for BCFKm can be calculated as in the full test.
Ako su dostupne i srednje podatkovne točke, granice pouzdanosti za vrijednost BCF Km moguće je izračunati kao u potpunom ispitivanju.
For the purpose of Regulation (EC) No 1907/2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) (OJ L 396, 30.12.2006, p. 1), this issue is addressed in the “Guidance on Information Requirements and Chemical Safety Assessment”, chapter R.7c, R.7.10.3.1; R.7.10.4.1; and figure R7.10-2.
Za potrebe Uredbe (EZ) br. 1907/2006 o registraciji, evaluaciji, autorizaciji i ograničavanju kemikalija (REACH) (SL L 396, 30.12.2006., str. 1.), to je pitanje uključeno u ‚Smjernice o zahtjevima obavješćivanja i procjeni kemijske sigurnosti’, poglavlja R.7c, R.7.10.3.1. i R.7.10.4.1. i slika R7.10-2.
As the BMF is defined as the ratio of the concentration of a substance in an organism to that in the organism's food at steady-state, lipid is taken into account by correcting for the contents of lipid in the organism and in the food, hence it is described more accurately as a “correction”.
Budući da je BMF definiran kao omjer koncentracije tvari u organizmu u odnosu na koncentraciju u hrani kojom se hrani organizam pri stabilnom stanju, lipide se uzima u obzir ispravljanjem vrijednosti u odnosu na sadržaj lipida u organizmu i u hrani te se stoga točnije opisuje kao ‚ispravljanje’.
This approach differs from “normalisation” to a set organism lipid content as is done in the aqueous exposure bioconcentration test.
Taj se pristup razlikuje od ‚normiranja’ na određeni sadržaj lipida u organizmu koji se primjenjuje u ispitivanju biokoncentracije vodenim izlaganjem.
Total length should also be recorded during the test as it is a good indicator of whether an adverse effect has occurred.
Tijekom ispitivanja trebalo bi evidentirati i ukupnu dužinu jer je ona dobar pokazatelj toga je li došlo do štetnog učinka.
HCB is listed in Annexes A and C to the Stockholm Convention, and in Annexes I and III of Regulation (EC) No 850/2004 on persistent organic pollutants (OJ L 158, 30.4.2004, p. 7)
HCB je naveden u prilozima A i C Stockholmskoj konvenciji te u prilozima I. i III. Uredbi (EZ) br. 850/2004 o postojanim organskim onečišćujućim tvarima (SL L 158, 30.4.2004., str. 7.).
For rapid growth during the uptake phase the true feeding rate will decrease below that set at the beginning of exposure.
Zbog brzog rasta u fazi apsorpcije stvarna brzina hranjenja bit će niža od one određene na početku izlaganja.
In an aqueous exposure study, a 14-day half-life would correspond to a BCF of ca. 10000 L/kg using fish of 1 g with a corresponding uptake rate of about 500 L/kg/d (according to the equation of Sijm et al (46)).
U ispitivanju vodenim izlaganjem 14-dnevni poluvijek odgovarao bi vrijednosti BCF-a od oko 10000 L/kg uz upotrebu ribe od 1 g, s odgovarajućom brzinom apsorpcije od oko 500 L/kg/dan (u skladu s jednadžbom Sijm et al (46)).
Since the actual internal concentrations can only be determined after the test has been performed, an estimate of the expected internal concentration is needed (e.g. based on the expected BMF and the concentration in the food; cf. Equation A5.8 in Appendix 5).
Budući da je stvarne unutarnje koncentracije moguće utvrditi tek nakon provođenja ispitivanja, potrebno je procijeniti očekivanu unutarnju koncentraciju (npr. na temelju očekivane vrijednosti BMF-a i koncentracije u hrani; vidjeti jednadžbu A5.8 u Dodatku 5.).
The presence of the test substance in the test medium as a result of excretion by the fish or leaching from food may not be totally avoidable.
Zbog izlučivanja riba ili ispiranja iz hrane možda neće biti moguće u potpunosti izbjeći prisutnost ispitivane tvari u ispitnom mediju.
Therefore one option is to measure the substance concentration in water at the end of the uptake period, especially if a semi-static set up is used, to help to establish whether any aqueous exposure has occurred.
Stoga je jedna od mogućnosti mjerenje koncentracije tvari u vodi na kraju razdoblja apsorpcije, posebno ako se upotrebljava polustatički postav, kako bi se omogućilo utvrđivanje toga je li došlo do vodenog izlaganja.
This approach is specific to the dietary study, distinct from the procedure followed in the aqueous exposure, hence the word “correction” has been used rather than “normalisation” to prevent confusion — see also footnote in paragraph 106.
Taj je pristup specifičan za ispitivanje kroz hranu, a razlikuje se od postupka koji se primjenjuje u vodenom izlaganju te je zato radi izbjegavanja zabune upotrijebljen izraz ‚ispravljanje’, a ne ‚normiranje’, vidjeti i bilješku u stavku 106.
A foodstuff analysis technique for protein, lipid, crude fibre and ash content; this information is usually available from the feed supplier.
Tehnika analize hrane u pogledu sadržaja proteina, lipida, sirovih vlakana i pepela; te je informacije uobičajeno moguće dobiti od dobavljača hrane.
CI confidence interval (where possible to estimate).
CI interval pouzdanosti (ako ga je moguće procijeniti)
SD Standard deviation (where possible to estimate).
SD standardna devijacija (ako ju je moguće procijeniti)
Other daphnids may be used provided they meet the validity criteria as appropriate (the validity criterion relating to the reproductive output in the controls should be relevant for all species).
Mogu se upotrebljavati i druge vrste dafnija pod uvjetom da su ispunjeni odgovarajući kriteriji valjanosti (kriterij valjanosti koji se odnosi na reproduktivnu uspješnost u kontrolama trebao bi biti relevantan za sve vrste).
If other daphnid are used they should be clearly identified and their use justified.
Ako se upotrebljavaju druge dafnije, one bi trebale biti jasno utvrđene, a njihova bi uporaba trebala biti opravdana.
Accidental mortality: non chemical related mortality caused by an accidental incidence (i.e. known cause)
Slučajna smrtnost: smrtnost koja nije povezana s kemikalijom i koja je uzrokovana slučajnim događajem (odnosno uzrok je poznat).
Inadvertent mortality: non chemical related mortality with no known cause
Nenamjerna smrtnost: smrtnost koja nije povezana s kemikalijom i kojoj nije poznat uzrok.
The test solution is determined by titration with the standard base or acid solution as appropriate, measuring the pH after each addition of titrant. At least 10 incremental additions should be made before the equivalence point.
Ispitna otopina određuje se titracijom standardnom otopinom baze ili kiseline, ovisno o slučaju, pri čemu se nakon svakog dodavanja titranta mjeri pH. Potrebno je izvršiti najmanje deset dodavanja prije točke ekvivalencije.
The degree of dissociation may then be calculated from the conductivity of each solution using the Onsager equation, and hence using the Ostwald Dilution Law the dissociation constant may be calculated as K = α2C/(1 – α) where C is the concentration in moles per litre and α is the fraction dissociated.
Potom se iz podataka za vodljivost svake otopine može izračunati stupanj disocijacije s pomoću Onsagerove jednadžbe te se iz toga, primjenom Ostwaldovog zakona razrjeđenja, može izračunati konstanta disocijacije s pomoću formule K = α2C/(1 – α) pri čemu je C koncentracija u molovima po litri, a α je disocirana frakcija.
Precautions must be taken to exclude CO2.
Moraju se poduzeti mjere opreza kako bi se isključio CO2.
Albert, A. & Sergeant, E.P.: Ionization Constants of Acids and Bases, Wiley, Inc., New York, 1962.
Albert, A. & Sergeant, E.P.: Ionization Constants of Acids and Bases, Wiley, Inc., New York, 1962.
Nelson, N.H.
Nelson, N.H.
3, II, pp. 1186-1188 (1969).
3, II, str. 1186. – 1188. (1969).
ASTM D 1293 — Annual ASTM Standards, Philadelphia, 1974.
ASTM D 1293 – Annual ASTM Standards, Philadelphia, 1974.
Standard Method 242.
Standard Method 242.
Clark, J. & Cunliffe, A.E.: Rapid spectrophotometric measurement of ionisation constants in aqueous solution.
Clark, J. & Cunliffe, A.E.: Rapid spectrophotometric measurement of ionisation constants in aqueous solution.
ASTM D 1125 — Annual ASTM Standards, Philadelphia, 1974.
ASTM D 1125 – Annual ASTM Standards, Philadelphia, 1974.
Handbook of Chemistry and Physics, 60th ed.
Handbook of Chemistry and Physics, 60th ed.
source, housing conditions, diet, etc.
podrijetlo životinja, uvjeti držanja, prehrana itd.
Anaesthetics and analgesics
Anestetici i analgetici
Barratt, M.D., et al.
Barratt, M.D., et al. (1995), The Integrated Use of Alternative Approaches for Predicting Toxic Hazard, ECVAM Workshop Report 8, ATLA 23, 410.
Worth A.P. and Fentem J.H.
Worth A.P. and Fentem J.H.
OECD (2000), Guidance Document on the Recognition, Assessment and Use of Clinical Signs as Humane Endpoints for Experimental Animals Used in Safety Evaluation.
OECD (2000), Guidance Document on the Recognition, Assessment and Use of Clinical Signs as Humane Endpoints for Experimental Animals Used in Safety Evaluation.
Wright EM, Marcella KL, Woodson JF.
Wright EM, Marcella KL, Woodson JF.
National Research Council (NRC) (2008), Recognition and Alleviation of Distress in Laboratory Animals, Washington, DC: The National Academies Press.
National Research Council (NRC) (2008), Recognition and Alleviation of Distress in Laboratory Animals, Washington, DC: The National Academies Press.
National Research Council (NRC) (2009), Recognition and Alleviation of Pain in Laboratory Animals, Washington, DC: The National Academies Press.
National Research Council (NRC) (2009), Recognition and Alleviation of Pain in Laboratory Animals, Washington, DC: The National Academies Press.
ICCVAM (2010), ICCVAM Test Method Evaluation Report: Recommendations for Routine Use of Topical Anesthetics, Systemic Analgesics, and Humane Endpoints to Avoid or Minimize Pain and Distress in Ocular Safety Testing, NIH Publication No. 10-7514, Research Triangle Park, NC, USA: National Institute of Environmental Health Sciences.
ICCVAM (2010), ICCVAM Test Method Evaluation Report: Recommendations for Routine Use of Topical Anesthetics, Systemic Analgesics, and Humane Endpoints to Avoid or Minimize Pain and Distress in Ocular Safety Testing, NIH Publication No. 10-7514, Research Triangle Park, NC, USA: National Institute of Environmental Health Sciences.
OECD (2006), Test No. 435: In vitro Membrane Barrier Test Method for Skin corrosion, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Paris.
OECD (2006), Test No. 435: In vitro Membrane Barrier Test Method for Skin corrosion, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Paris.
U.S.
U.S.
UN (2011), Globally Harmonized System of Classification and Labelling of Chemicals (GHS), Fourth revised edition, New York & Geneva: United Nations Publications.
UN (2011), Globally Harmonized System of Classification and Labelling of Chemicals (GHS), Fourth revised edition, New York & Geneva: United Nations Publications.
ECHA Guidance on information requirements and chemical safety assessment, Chapter R.7a: Endpoint specific guidance.
ECHA Guidance on information requirements and chemical safety assessment, Chapter R.7a: Endpoint specific guidance.
A chemical that produces a reversible change in the eye; (b) Chemicals that are classified as EPA Category II or III ocular irritants; or GHS eye irritants Category 2, 2A or 2B; or EU Category 2 (17) (18) (19).
Kemikalija koja dovodi do reverzibilne promjene u oku; (b) Kemikalije koje su razvrstane kao tvari nadražujuće za oči II. ili III. kategorije EPA-e; ili kao tvari nadražujuće za oči 2., 2.A ili 2.B kategorije GHS-a; ili 2. kategorije EU-a (17., 18., 19.).
A chemical that causes tissue damage in the eye that does not resolve within 21 days of application or causes serious physical decay of vision; (b) Chemicals that are classified as GHS eye irritant Category 1, or EPA Category I ocular irritants, or EU Category 1 (17) (18) (19).
Kemikalija koja uzrokuje oštećenje očnog tkiva koje nije reverzibilno unutar 21 dana od primjene ili uzrokuje ozbiljno fizičko pogoršanje vida; (b) Kemikalije koje su razvrstane kao tvari nadražujuće za oči 1. kategorije GHS-a ili I. kategorije EPA-e ili 1. kategorije EU-a (17., 18., 19.).
Tiered approach
Višerazinski pristup
OECD (1998) Harmonized Integrated Hazard Classification System for Human Health and Environmental Effects of Chemical Substances, as endorsed by the 28th Joint Meeting of the Chemicals Committee and the Working Party on Chemicals, November 1998 (http://www.oecd.org/ehs/Class/HCL6.htm).
OECD (1998) Harmonized Integrated Hazard Classification System for Human Health and Environmental Effects of Chemical Substances, as endorsed by the 28th Joint Meeting of the Chemicals Committee and the Working Party on Chemicals, studeni 1998. (http://www.oecd.org/ehs/Class/HCL6.htm).
Worth, A.P. and Fentem J.H.
Worth, A.P. and Fentem J.H.
In Vitro Mammalian Chromosomal Aberration Test
In vitro ispitivanje kromosomskih aberacija kod sisavaca
CASRN
CAS br.
Evans, H.J.
Evans, H.J.
Galloway, S.M. et al.
Galloway, S.M. et al. (1994).
10, pp. 1-175.
10, str. 1.–175.
Muehlbauer, P.A. et al.
Muehlbauer, P.A. et al. (2008), ‚Improving dose selection and identification of aneugens in the in vitro chromosome aberration test by integration of flow cytometry-based methods’, Environmental and Molecular Mutagenesis, Vol. 49/4, str. 318.
ILSI paper (draft), Lorge, E., M. Moore, J. Clements, M. O Donovan, F. Darroudi, M. Honma, A. Czich, J van Benthem, S. Galloway, V. Thybaud, B. Gollapudi, M. Aardema, J. Kim, D.J.
ILSI paper (draft), Lorge, E., M. Moore, J. Clements, M. O Donovan, F. Darroudi, M. Honma, A. Czich, J van Benthem, S. Galloway, V. Thybaud, B. Gollapudi, M. Aardema, J. Kim, D.J.
Scott, D. et al.
Scott, D. et al. (1991).
A report from ICPEMC Task Group 9, Mutation Research/Reviews in Genetic Toxicology, Vol.257/2, pp. 147-204.
A report from ICPEMC Task Group 9, Mutation Research/Reviews in Genetic Toxicology, Vol. 257/2, str. 147. – 204.
Morita, T. et al.
Morita, T. et al. (1992).
Brusick, D. (1986), Genotoxic effects in cultured mammalian cells produced by low pH treatment conditions and increased ion concentrations, Environmental and Molecular Mutagenesis, Vol. 8/6, pp. 789-886.
Brusick, D. (1986), Genotoxic effects in cultured mammalian cells produced by low pH treatment conditions and increased ion concentrations, Environmental and Molecular Mutagenesis, Vol. 8/6, str. 789. – 886.
Long, L.H. et al.
Long, L.H. et al. (2007).
Nesslany, F. et al.
Nesslany, F. et al. (2008).
Galloway, S. (2000), Cytotoxicity and chromosome aberrations in vitro: Experience in industry and the case for an upper limit on toxicity in the aberration assay, Environmental and Molecular Mutagenesis, Vol. 35/3, pp. 191-201.
Galloway, S. (2000), Cytotoxicity and chromosome aberrations in vitro: Experience in industry and the case for an upper limit on toxicity in the aberration assay, Environmental and Molecular Mutagenesis, Vol. 35/3, str. 191. – 201.
I: Sensitivity, specificity and relative predictivity, Mutation Research/Genetic Toxicology and Environmental Mutagenesis, Vol. 584/1-2, pp. 1–256.
I: Sensitivity, specificity and relative predictivity, Mutation Research/Genetic Toxicology and Environmental Mutagenesis, Vol. 584/1-2, str. 1. – 256.
Hilliard, C.A. et al.
Hilliard, C.A. et al. (1998), Chromosome aberrations in vitro related to cytotoxicity of nonmutagenic chemicals and metabolic poisons, Environmental and Molecular Mutagenesis, Vol. 31/4, str. 316.
Hedner K. et al.
Hedner K. et al. (1982), Sister chromatid exchanges and structural chromosomal aberrations in relation to age and sex, Human Genetics, Vol. 62, str. 305.
Ramsey M.J. et al.
Ramsey M.J. et al. (1995), The effects of age and lifestyle factors on the accumulation of cytogenetic damage as measured by chromosome painting, Mutation Research, Vol. 338, str. 95.
A Report of the Second ECVAM Task Force on Good Cell Culture Practice, ATLA, Vol. 33/3, pp. 261-287.
A Report of the Second ECVAM Task Force on Good Cell Culture Practice, ATLA, Vol. 33/3, str. 261. – 287.
Henderson, L. et al.
Henderson, L. et al. (1997), Industrial Genotoxicology Group collaborative trial to investigate cell cycle parameters in human lymphocyte cytogenetics studies, Mutagenesis, Vol.12/3, str. 163.
Maron, D.M., B.N.
Maron, D.M., B.N.
Ames (1983), Revised Methods for the Salmonella Mutagenicity Test, Mutation Research/Environmental Mutagenesis and Related Subjects, Vol. 113/3-4, pp. 173-215.
Ames (1983), Revised Methods for the Salmonella Mutagenicity Test, Mutation Research/Environmental Mutagenesis and Related Subjects, Vol. 113/3-4, str. 173. – 215.
Natarajan, A.T. et al.
Natarajan, A.T. et al. (1976), Cytogenetic Effects of Mutagens/Carcinogens after Activation in a Microsomal System In Vitro, I. Induction of Chromosomal Aberrations and Sister Chromatid Exchanges by Diethylnitrosamine (DEN) and Dimethylnitrosamine (DMN) in CHO Cells in the Presence of Rat-Liver Microsomes, Mutation Research, Vol. 37/1, str. 83.
Matsuoka, A., M. Hayashi, M. Jr.
Matsuoka, A., M. Hayashi, M. Jr.
Ong, T.-m. et al.
Ong, T.-m. et al. (1980).
Alternatives to Aroclor 1254-induced S9 in in vitro Genotoxicity Assays, Mutagenesis, Vol. 7/3, pp. 175-177.
Alternatives to Aroclor 1254-induced S9 in in vitro Genotoxicity Assays, Mutagenesis, Vol. 7/3, str. 175. – 177.
Matsushima, T. et al.
Matsushima, T. et al. (1999).
Report from Working Group on in vitro Tests for Chromosomal Aberrations, Mutation Research/Environmental Mutagenesis and Related Subjects, Vol. 312/3, pp. 241-261.
Report from Working Group on in vitro Tests for Chromosomal Aberrations, Mutation Research/Environmental Mutagenesis and Related Subjects, Vol. 312/3, str. 241. – 261.
Johnson, T.E., D.R.
Johnson, T.E., D.R.
UNEP (2001), Stockholm Convention on Persistent Organic Pollutants, United Nations Environment Programme (UNEP).
UNEP (2001), Stockholmska konvencija o postojanim organskim onečišćujućim tvarima, Program Ujedinjenih naroda za zaštitu okoliša (UNEP).
Tucker, J.D., M.L.
Tucker, J.D., M.L.
Christensen (1987), Effects of anticoagulants upon sister-chromatid exchanges, cell-cycle kinetics, and mitotic index in human peripheral lymphocytes, Mutation Research, Vol. 190/3, pp. 225-8.
Christensen (1987), Effects of anticoagulants upon sister-chromatid exchanges, cell-cycle kinetics, and mitotic index in human peripheral lymphocytes, Mutation Research, Vol. 190/3, str. 225. – 8.
Krahn, D.F., F.C.
Krahn, D.F., F.C.
Zamora, P.O. et al.
Zamora, P.O. et al. (1983).
Asakura, M. et al.
Asakura, M. et al. (2008).
Lorge, E. et al.
Lorge, E. et al. (2006).
I. Theoretical aspects, Mutation Research/Genetic Toxicology and Environmental Mutagenesis, Vol. 655/1-2, pp. 1-3.
I. Theoretical aspects, Mutation Research/Genetic Toxicology and Environmental Mutagenesis, Vol. 655/1-2, str. 1. – 3.
Galloway, S. et al.
Galloway, S. et al. (2011), Workshop summary: Top concentration for in vitro mammalian cell genotoxicity assays; and Report from working group on toxicity measures and top concentration for in vitro cytogenetics assays (chromosome aberrations and micronucleus), Mutation Research/Genetic Toxicology and Environmental Mutagenesis, Vol. 723/2, str. 77.
Honma, M. (2011), Cytotoxicity measurement in in vitro chromosome aberration test and micronucleus test, Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, Vol. 724/1-2, pp. 86-87.
Honma, M. (2011), Cytotoxicity measurement in in vitro chromosome aberration test and micronucleus test, Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, Vol. 724/1-2, str. 86. – 87.
Richardson, C. et al.
Richardson, C. et al. (1989).
OECD (2014), Document supporting the WNT decision to implement revised criteria for the selection of the top concentration in the in vitro mammalian cell assays on genotoxicity (Test Guidelines 473, 476 and 487) ENV/JM/TG(2014)17.
OECD (2014), Document supporting the WNT decision to implement revised criteria for the selection of the top concentration in the in vitro mammalian cell assays on genotoxicity (Test Guidelines 473, 476 and 487) ENV/JM/TG(2014)17.
Morita, T., M. Honma, K. Morikawa (2012), Effect of reducing the top concentration used in the in vitro chromosomal aberration test in CHL cells on the evaluation of industrial chemical genotoxicity, Mutation Research/Genetic Toxicology and Environmental Mutagenesis, Vol. 741/1-2, pp. 32-56.
Morita, T., M. Honma, K. Morikawa (2012), Effect of reducing the top concentration used in the in vitro chromosomal aberration test in CHL cells on the evaluation of industrial chemical genotoxicity, Mutation Research/Genetic Toxicology and Environmental Mutagenesis, Vol. 741/1-2, str. 32. – 56.
Levy (2013), Evaluation of the Highest Concentrations Used in the In Vitro Chromosome Aberrations Assay, Environmental and Molecular Muagenesis, Vol. 54/1, pp. 36-43.
Chen, D.D. Levy (2013), Evaluation of the Highest Concentrations Used in the In Vitro Chromosome Aberrations Assay, Environmental and Molecular Mutagenesis, Vol. 54/1, str. 36. – 43.
EPA, Office of Chemical Safety and Pollution Prevention (2011), Chemical Substances of Unknown or Variable Composition, Complex Reaction Products and Biological Materials: UVCB Substances, http://www.epa.gov/opptintr/newchems/pubs/uvcb.txt.
EPA, Ured za kemijsku sigurnost i sprječavanje onečišćenja (2011), Kemijske tvari nepoznatog ili promjenjivog sastava, složeni reakcijski proizvodi i biološki materijal: UVCB tvari, http://www.epa.gov/opptintr/newchems/pubs/uvcb.txt.
USFDA (2012), International Conference on Harmonisation (ICH) Guidance S2 (R1) on Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended For Human Use.
USFDA (2012), International Conference on Harmonisation (ICH) Guidance S2 (R1) on Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended For Human Use.
ISCN (2013), An International System for Human Cytogenetic Nomenclature, Schaffer, L.G., J. MacGowan-Gordon, M. Schmid (eds.), Karger Publishers Inc., Connecticut.
ISCN (2013), An International System for Human Cytogenetic Nomenclature, Schaffer, L.G., J. MacGowan-Gordon, M. Schmid (eds.), Karger Publishers Inc., Connecticut.
Hayashi, M. et al.
Hayashi, M. et al. (2010).
Ryan, T. P. (2000), Statistical Methods for Quality Improvement, 2nd Edition, John Wiley and Sons, New York.
Ryan, T. P. (2000), Statistical Methods for Quality Improvement, 2nd Edition, John Wiley and Sons, New York.
Fleiss, J. L., B. Levin, M.C.
Fleiss, J. L., B. Levin, M.C.
Warr, T.J., E.M.
Warr, T.J., E.M.